Come up with a name for your new list and we'll add to it:
Vaxil BioTherapeutics raised a round of funding on March 10, 2016. Investors include
Emerge Resources Corp..
Vaxil BioTherapeutics is a biotechnology firm focused on cancer treatments. Years of research have culminated in a significant cancer immunotherapy vaccine platform including a lead cancer vaccine can…